Quick Answer
Edesa Biotech, Inc. reported Diluted EPS of $0.57 per share (loss) for fiscal year 2016.
Edesa Biotech, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2016 | -$0.57 | -58.3% |
| 2015 | -$0.36 | -376.9% |
| 2014 | $0.13 | +111.7% |
| 2014 | -$1.11 | +60.5% |
| 2013 | -$2.81 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| June 30, 2016 | -$0.14 | -380.0% | -380.0% |
| June 30, 2015 | $0.05 | +25.0% | +600.0% |
| March 31, 2015 | -$0.01 | +50.0% | +50.0% |
| December 31, 2014 | -$0.02 | +75.0% | -300.0% |
| September 30, 2014 | $0.01 | — | -75.0% |
| June 30, 2014 | $0.04 | — | +300.0% |
| March 31, 2014 | -$0.02 | — | +75.0% |
| December 31, 2013 | -$0.08 | — | — |
- Edesa Biotech, Inc. showed a decrease of -58.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2013–2016 period, Edesa Biotech, Inc.’s diluted eps has grown by 79.7% (from $2.81 per share (loss) to $0.57 per share (loss)).
- The most recent figure is from Edesa Biotech, Inc.’s fiscal year 2016 report (Form 10-K), filed with the SEC on December 14, 2016.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: